Precision Medicine News and Research

RSS

Novel personalized medicine tool for assessing inherited colorectal cancer syndrome risk developed

An international team of researchers led by Huntsman Cancer Institute at the University of Utah has developed, calibrated, and validated a novel tool for identifying the genetic changes in Lynch syndrome genes that are likely to be responsible for causing symptoms of the disease.

10 Dec 2018

Cancer Research UK and AstraZeneca open new Functional Genomics Centre

Cancer Research UK and AstraZeneca have announced today (Monday) that they are opening a new center in the UK, dedicated to realizing the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.

10 Dec 2018

New diagnostic tools may help identify breast cancer patients who could benefit from targeted therapies

A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.

7 Dec 2018

Researchers use new methods to optimize treatments for tuberculosis meningitis

Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain--or tuberculosis meningitis (TBM)--is often deadly, always hard to treat, and a particular threat to young children.

6 Dec 2018

Researchers develop biosensors to detect and measure metastatic potential of cancer cells

The spread of invasive cancer cells from a tumor's original site to distant parts of the body is known as metastasis. It is the leading cause of death in people with cancer. In a paper published online in iScience, University of California San Diego School of Medicine researchers reported engineering sensors that can detect and measure the metastatic potential of single cancer cells.

6 Dec 2018

New version of InSyBio Suite launched to revolutionize biomarker discovery

The new version of InSyBio Suite has a significant increase in speed and refinement of the predictive biomarkers process.

5 Dec 2018

New approach turns B cells into factories that secrete sacs containing microRNAs

Cancer immunotherapy -- efforts to better arm a patient's own immune system to attack tumors -- has shown great potential for treating some cancers. Yet immunotherapy doesn't work for everyone, and some types of treatment can cause serious side effects.

5 Dec 2018

Researchers create new approach to classify patients with Alzheimer's disease

Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments.

5 Dec 2018

FDA takes significant step forward in driving development of novel genetic tests

The U.S. Food and Drug Administration today took a significant step forward in driving the efficient development of novel diagnostic technologies that scan a person's DNA to diagnose genetic diseases and guide medical treatments.

5 Dec 2018

Advances in gene therapy for inherited blood disorders

Gene therapy holds a lot of promise in medicine. If we could safely alter our own DNA, we might eliminate diseases our ancestors passed down to us.

4 Dec 2018

Sema4, Mount Sinai, Sanofi announce launch of new collaborative asthma study

Sema4, a patient-centered predictive health company, and the Mount Sinai Health System today announced the launch of a five-year collaborative study with Sanofi designed to provide new insights into the biological mechanisms and other factors implicated in asthma.

4 Dec 2018

UK scientists find new way to identify patients with aggressive lymphoma

UK scientists have found a new way to identify people with the most aggressive types of lymphoma who are less likely to respond to standard drugs.

3 Dec 2018

Aurora Biomed organizes 2018 Shunde Biomedical Industry Investment Promotion Conference

From November 14-17, the "2018 Shunde Biomedical Industry Investment Promotion Conference" which ran in parallel with the Precision Medicine and Ion Channel Retreat was successfully held at the Ramada Plaza Hotel, Shunde, Guang Dong, China.

3 Dec 2018

First-of-its-kind undertaking to study genetic, biological factors that contribute to development of opioid use disorder

The Coriell Institute for Medical Research, Cooper University Health Care and Cooper Medical School of Rowan University (CMSRU) are launching the Camden Opioid Research Initiative (CORI), a first-of-its-kind undertaking to investigate the genetic and biological factors that contribute to the development of opioid use disorder (also referred to as opioid dependence or addiction).

29 Nov 2018

Insights from the Shunde Biomedical Industry Investment Promotion Conference

From November 14-17, the 2018 Shunde Biomedical Industry Investment Promotion Conference was successfully held at the Ramada Plaza Hotel, Shunde, GuangDong, China

From Aurora Biomed Inc. 29 Nov 2018

Ground-breaking computer models could boost treatment of common cardiac condition

Ground-breaking computer models that simulate the workings of individual patients' hearts could boost treatment of a common cardiac condition that affects a million people in the UK and countless more worldwide.

27 Nov 2018

Policy and law key to ensure health equity in precision medicine

Genomics has a diversity problem. Despite the dazzling promise of genetically-tailored treatments and therapies, fundamental questions remain about whether precision medicine will advance health equity or make disparities worse.

27 Nov 2018

CytoReason announces publication of new model for translating data from mouse models to human disease

CytoReason, developer of the world's first machine learning platform for human immune system cell-level simulation, today announces publication of a groundbreaking new model for translating data from mouse models to human disease.

27 Nov 2018

UC San Francisco scientists identify 'Achilles heel' of drug-resistant cancers

UC San Francisco scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies.

27 Nov 2018

AI and Big Data enable better diagnosis, personalized treatment of eye diseases

"Exactly one year ago, we spoke about the fact that, in future, it will be possible to diagnose diabetes from the eye using automatic digital retinal screening, without the assistance of an ophthalmologist – 12 months on, MedUni Vienna is right in the middle of this digital revolution." These were the words used by Ursula Schmidt-Erfurth, Head of MedUni Vienna's Department of Ophthalmology and Optometrics to open today's press conference about the ART-2018 Specialist Meeting on new developments in retinal therapy, which is to take place on 1 December.

22 Nov 2018

Precision Medicine News and Research

Novel personalized medicine tool for assessing inherited colorectal cancer syndrome risk developed

Cancer Research UK and AstraZeneca open new Functional Genomics Centre

New diagnostic tools may help identify breast cancer patients who could benefit from targeted therapies

Researchers use new methods to optimize treatments for tuberculosis meningitis

Researchers develop biosensors to detect and measure metastatic potential of cancer cells

New version of InSyBio Suite launched to revolutionize biomarker discovery

New approach turns B cells into factories that secrete sacs containing microRNAs

Researchers create new approach to classify patients with Alzheimer's disease

FDA takes significant step forward in driving development of novel genetic tests

Advances in gene therapy for inherited blood disorders

Sema4, Mount Sinai, Sanofi announce launch of new collaborative asthma study

UK scientists find new way to identify patients with aggressive lymphoma

Aurora Biomed organizes 2018 Shunde Biomedical Industry Investment Promotion Conference

First-of-its-kind undertaking to study genetic, biological factors that contribute to development of opioid use disorder

Insights from the Shunde Biomedical Industry Investment Promotion Conference

Ground-breaking computer models could boost treatment of common cardiac condition

Policy and law key to ensure health equity in precision medicine

CytoReason announces publication of new model for translating data from mouse models to human disease

UC San Francisco scientists identify 'Achilles heel' of drug-resistant cancers

AI and Big Data enable better diagnosis, personalized treatment of eye diseases

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News